72 results on '"Liu, Qiaofei"'
Search Results
2. Long-term Sustained Clinical Remission of Peritoneal Metastatic Pancreatic Ductal Adenocarcinoma After Sequential Chemoradiation Therapy: A Case Report
3. Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: The intratumor heterogeneity, functional phenotypes, and cellular interactions
4. Heparin-induced thrombocytopenia thrombosis (HITT) after pancreaticoduodenectomy without definitive prophylactic or therapeutic use of heparin: a case report
5. Local resection for solid pseudopapillary neoplasms of the pancreas shows improved postoperative gastrointestinal function and reduced mental stress: a multi-questionnaire survey from a large cohort
6. Long-Term Survival, Quality Of Life, And Molecular Features Of The Patients With Solid Pseudopapillary Neoplasm Of The Pancreas
7. Data from Antigen Presentation by Dendritic Cells in Tumors Is Disrupted by Altered Metabolism that Involves Pyruvate Kinase M2 and Its Interaction with SOCS3
8. Supplementary Figures 1-7 from Antigen Presentation by Dendritic Cells in Tumors Is Disrupted by Altered Metabolism that Involves Pyruvate Kinase M2 and Its Interaction with SOCS3
9. Data from Antigen Presentation by Dendritic Cells in Tumors Is Disrupted by Altered Metabolism that Involves Pyruvate Kinase M2 and Its Interaction with SOCS3
10. Supplementary Figures 1-7 from Antigen Presentation by Dendritic Cells in Tumors Is Disrupted by Altered Metabolism that Involves Pyruvate Kinase M2 and Its Interaction with SOCS3
11. Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
12. Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth
13. Prognostic value of preoperative [68 Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics
14. Identifying the preoperative factors predicting the surgical difficulty of robotic distal pancreatectomy
15. Comprehensive analysis of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs): A SEER database analysis of 767 cases
16. Glycosylation of immunoglobin G in tumors: Function, regulation and clinical implications
17. GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma
18. Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma
19. GREM1 is a Novel Serum Diagnostic Marker and Potential Therapeutic Target for Pancreatic Ductal Adenocarcinoma
20. Survey on the current status of the diagnosis and treatment of pancreatic cancer in public tertiary hospitals in China: a cross-sectional questionnaire-based, observational study
21. Knockdown of LRRN1 inhibits malignant phenotypes through the regulation of HIF-1α/Notch pathway in pancreatic ductal adenocarcinoma
22. Risk factors and prevention of postoperative pancreatic fistula after insulinoma enucleation:a retrospective study from a high-volume center
23. Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
24. Early Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy
25. CD58 Immunobiology at a Glance
26. Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis
27. Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
28. Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations
29. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming
30. Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatosplenectomy (CDPS) for left-sided pancreatic ductal adenocarcinoma
31. High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum
32. Immune Subtyping for Pancreatic Cancer with Implication in Clinical Outcomes and Improving Immunotherapy
33. Long noncoding RNA: a dazzling dancer in tumor immune microenvironment
34. Up‐regulation of CDHR5 expression promotes malignant phenotype of pancreatic ductal adenocarcinoma
35. Correction to: Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis
36. Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis
37. Identification of Prognosis-Related Genes and Construction of Multi-regulatory Networks in Pancreatic Cancer Microenvironment by Bioinformatics Analysis
38. Circular RNA and tumor microenvironment
39. Early drain removal after major pancreatectomy reduces postoperative complications: a single-center, randomized, controlled trial
40. Identification of Prognosis-Related Genes and Construction of Multi-regulatory Networks in Pancreatic Cancer Microenvironment by Bioinformatics Analysis
41. Identification of Prognosis-Related Genes and Construction of Multi-regulatory Networks in Pancreatic Cancer Microenvironment by Bioinformatics Analysis
42. Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment
43. Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review
44. Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
45. CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
46. High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma
47. Role of the complement system in the tumor microenvironment
48. Pancreatic cancer-educated macrophages protect cancer cells from complement-dependent cytotoxicity by up-regulation of CD59
49. Tumor-Associated Macrophages Protect Pancreatic Cancer from Complement-Dependent Cytotoxicity by Up-Regulation of Complement Regulator CD59 via IL-6R/STAT3 Signaling Pathway
50. Fibroblast activation protein α-positive pancreatic stellate cells promote the migration and invasion of pancreatic cancer by CXCL1-mediated Akt phosphorylation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.